A61P 35/00
Antineoplastic agents
A61P35/00 (Antineoplastic agents) appears on 88,627 US grants and 147,386 published applications in this corpus.
Search patents in A61P- Granted patents
- 88,627
- Published applications
- 147,386
- Assignees
- 24,672
- Inventors
- 174,174
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 14 | 0 |
| 1978 | 38 | 0 |
| 1979 | 38 | 0 |
| 1980 | 72 | 0 |
| 1981 | 61 | 0 |
| 1982 | 69 | 0 |
| 1983 | 79 | 0 |
| 1984 | 97 | 0 |
| 1985 | 101 | 0 |
| 1986 | 98 | 0 |
| 1987 | 122 | 0 |
| 1988 | 144 | 0 |
| 1989 | 219 | 0 |
| 1990 | 215 | 0 |
| 1991 | 222 | 0 |
| 1992 | 227 | 0 |
| 1993 | 215 | 0 |
| 1994 | 224 | 0 |
| 1995 | 348 | 0 |
| 1996 | 488 | 0 |
| 1997 | 704 | 0 |
| 1998 | 1009 | 0 |
| 1999 | 1113 | 0 |
| 2000 | 1143 | 0 |
| 2001 | 1332 | 409 |
| 2002 | 1443 | 2232 |
| 2003 | 1510 | 3525 |
| 2004 | 1180 | 4205 |
| 2005 | 1206 | 4247 |
| 2006 | 1730 | 4366 |
| 2007 | 1750 | 4343 |
| 2008 | 2037 | 5363 |
| 2009 | 2330 | 6346 |
| 2010 | 3272 | 7276 |
| 2011 | 3299 | 7106 |
| 2012 | 3950 | 6616 |
| 2013 | 4613 | 5632 |
| 2014 | 4618 | 5821 |
| 2015 | 4330 | 5707 |
| 2016 | 4004 | 5932 |
| 2017 | 4283 | 5758 |
| 2018 | 3969 | 6510 |
| 2019 | 4393 | 7297 |
| 2020 | 4597 | 7072 |
| 2021 | 4293 | 7305 |
| 2022 | 3914 | 7700 |
| 2023 | 3404 | 7646 |
| 2024 | 3737 | 7622 |
| 2025 | 3854 | 6634 |
| 2026 | 2510 | 4716 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Liposomal enhanced intra-peritoneal chemotherapy6 Oct 2026US 12,751,919 B2
- Benzenesulfonamide derivatives and method for treating cancer6 Oct 2026US 12,751,936 B2Gongwin Biopharm Co., Ltd
- Therapeutic uses of inhibitors of the RNA-binding protein HuR6 Oct 2026US 12,751,938 B2University of Kansas
- CDK inhibitors6 Oct 2026US 12,751,951 B2Genentech, Inc.
- Quinazoline derivative, or preparation method therefor and use thereof6 Oct 2026US 12,751,952 B2Shanghai Aryl Pharmtech Co., Ltd.
- Aqueous formulations comprising fullerene, structured water, dissolved hydrogen gas, minerals and additives8 Oct 2026US 2026/0306402 A1Best Planet Science LLC
- Liposome compositions and medical uses thereof8 Oct 2026US 2026/0306404 A1
- Tretinoin liposome formulations and uses thereof to treat cancer8 Oct 2026US 2026/0306436 A1Highfield Biopharmaceuticals Corporation
- Compositions and methods for treating cancer by targeting bach18 Oct 2026US 2026/0306455 A1
- Inhibitors of nsun1- and nsun2-mediated active structures8 Oct 2026US 2026/0306459 A1
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Drug releasing biodegradable fiber implant1,662US 6,596,296 B1Board of Regents, The University of Texas System · 2003
- Modular infusion device and method1,554US 6,749,587 B2Insulet Corporation · 2004